FdaApplication
BLA 208673
Identifiers
- fda_app_no: BLA208673
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2016-11-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SOLIQUA 100/33 | INSULIN GLARGINE; LIXISENATIDE | 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML | Injection |
1 product